Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations (Q34738805)

4 August 2017

1 reference

title

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations (English)

1 reference

4 August 2017

0 references

0 references

1 reference

Barry M

1

1 reference

4 August 2017

Gibbons S

series ordinal

2

1 reference

4 August 2017

Back D

series ordinal

3

1 reference

4 August 2017

Mulcahy F

series ordinal

4

1 reference

4 August 2017

publication date

1 March 1997

1 reference

Clinical Pharmacokinetics

4 August 2017

published in

1 reference

4 August 2017

volume

32

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

194-209

1 reference

Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers

4 August 2017

cites work

1 reference

12 December 2020

Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells

1 reference

12 December 2020

Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

12 December 2020

Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

12 December 2020

A potentially hazardous interaction between erythromycin and midazolam.

1 reference

12 December 2020

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes

1 reference

12 December 2020

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

1 reference

12 December 2020

Current knowledge and future prospects for the use of HIV protease inhibitors

1 reference

12 December 2020

Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function

1 reference

12 December 2020

Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy

1 reference

12 December 2020

Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT Trial

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study

1 reference

12 December 2020

Adverse reactions to co-trimoxazole in HIV infection

1 reference

12 December 2020

Combination superior to zidovudine in Delta trial

1 reference

12 December 2020

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

12 December 2020

Clinical pharmacokinetics of rifabutin.

1 reference

12 December 2020

A new definition for AIDS surveillance

1 reference

12 December 2020

The plasma protein binding of basic drugs

1 reference

12 December 2020

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group

1 reference

12 December 2020

Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations

1 reference

12 December 2020

Zalcitabine and didanosine

1 reference

12 December 2020

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

1 reference

12 December 2020

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group

1 reference

12 December 2020

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

1 reference

12 December 2020

Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).

1 reference

12 December 2020

Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes

1 reference

12 December 2020

A computer simulation of the food effect: transient changes in hepatic blood flow and Michaelis-Menten parameters as mediators of hepatic first pass metabolism and bioavailability of propranolol

1 reference

12 December 2020

Review: first-pass metabolism by the gastrointestinal mucosa.

1 reference

12 December 2020

Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.

1 reference

12 December 2020

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

12 December 2020

Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy

1 reference

12 December 2020

Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis

1 reference

12 December 2020

Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.

1 reference

12 December 2020

Clinical significance of pharmacokinetic models of hepatic elimination

1 reference

12 December 2020

Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors

1 reference

12 December 2020

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

1 reference

12 December 2020

Clinical implications of enzyme induction

1 reference

12 December 2020

Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Safety and activity of saquinavir in HIV infection

1 reference

12 December 2020

The human hepatic cytochromes P450 involved in drug metabolism

1 reference

12 December 2020

Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice

1 reference

12 December 2020

Warfarin-phenylbutazone interaction in man: a long term multiple dose study

1 reference

12 December 2020

Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins

1 reference

12 December 2020

Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers

1 reference

12 December 2020

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides

1 reference

12 December 2020

The HIV-1 protease as a therapeutic target for AIDS

1 reference

12 December 2020

CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients

1 reference

12 December 2020

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

1 reference

12 December 2020

Plasma protein binding and pharmacological response

1 reference

12 December 2020

N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity

1 reference

12 December 2020

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections

1 reference

12 December 2020

Enzyme induction and inhibition

1 reference

12 December 2020

Metabolism of 2',3'-dideoxyinosine (ddI) in human blood

1 reference

12 December 2020

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

1 reference

12 December 2020

Enteropathy associated with the acquired immunodeficiency syndrome

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Prevention and treatment of pneumocystis pneumonia

1 reference

12 December 2020

Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)

1 reference

12 December 2020

Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Guidelines on the management of tuberculosis and HIV infection in the United Kingdom. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society

1 reference

12 December 2020

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

12 December 2020

Drug therapy. Binding of drugs to serum albumin (second of two parts)

1 reference

12 December 2020

Individual variation in first-pass metabolism

1 reference

12 December 2020

The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole

1 reference

12 December 2020

Drug Interactions with Oral Sulphonylurea Hypoglycaemic Drugs

1 reference

12 December 2020

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum alpha 1 acid glycoprotein.

1 reference

12 December 2020

Phenobarbital induction of cytochrome P-450 gene expression

1 reference

12 December 2020

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

1 reference

12 December 2020

Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends

1 reference

12 December 2020

What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions?

1 reference

12 December 2020

Clinical pharmacokinetics in patients with liver disease

1 reference

12 December 2020

Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients

1 reference

12 December 2020

The liver in the acquired immunodeficiency syndrome: a clinical and histologic study

1 reference

12 December 2020

Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer

1 reference

12 December 2020

Clinical Implications of Enzyme Induction and Enzyme Inhibition

1 reference

12 December 2020

Alterations in gastric acidity in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study

1 reference

12 December 2020

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee

1 reference

12 December 2020

Ketoconazole to reduce the need for cyclosporine after cardiac transplantation

1 reference

12 December 2020

Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4

1 reference

12 December 2020

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin

1 reference

12 December 2020

Hepatobiliary manifestations of the acquired immune deficiency syndrome

1 reference

12 December 2020

Human immunodeficiency virus. Protease uninhibited

1 reference

12 December 2020

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

A year of transformation in HIV/AIDS.

1 reference

12 December 2020

Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.

1 reference

12 December 2020

Interactions of the human immunodeficiency virus and the hepatotropic viruses

1 reference

12 December 2020

Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitor

1 reference

12 December 2020

Comparative pharmacokinetics of antiviral nucleoside analogues

1 reference

12 December 2020

Pharmacokinetic drug interactions with rifampicin

1 reference

12 December 2020

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

1 reference

12 December 2020

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

12 December 2020

Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy

1 reference

12 December 2020

10.2165/00003088-199732030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1032273114

0 references

1 reference